Last Updated: September 24, 2026

Ammonia n-13 - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for ammonia n-13 and what is the scope of patent protection?

Ammonia n-13 is the generic ingredient in one branded drug marketed by 3d Imaging Drug, Biomedcl Res Fdn, Brigham Womens Hosp, Cardinal Hlth 414, Central Radiopharm, Essential Isotopes, Feinstein, Gen Hosp, Ionetix, Johns Hopkins Univ, Kreitchman Pet Ctr, Mcprf, Methodist, Midwest Medcl, Mips Crf, Ncm Usa Bronx Llc, Nukemed, Petnet, Precision Nuclear, Shertech Labs Llc, Sofie, Ucla Biomedical, Ucsf Rodiopharm, Univ Alahama Birm, Univ Tx Md Anderson, Univ Tx Sw Medctr, Univ Wisconsin, Wa Univ Sch Med, and Wisconsin, and is included in thirty-one NDAs. Additional information is available in the individual branded drug profile pages.

Nineteen suppliers are listed for this compound.

Summary for ammonia n-13
US Patents:0
Tradenames:1
Applicants:29
NDAs:31
Finished Product Suppliers / Packagers: 19
Raw Ingredient (Bulk) Api Vendors: 6
Clinical Trials: 116
Patent Applications: 3,322
What excipients (inactive ingredients) are in ammonia n-13?ammonia n-13 excipients list
DailyMed Link:ammonia n-13 at DailyMed
Recent Clinical Trials for ammonia n-13

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mansoura UniversityPHASE4
Universit de MontralPHASE4
Université de SherbrookePHASE2

See all ammonia n-13 clinical trials

Pharmacology for ammonia n-13

US Patents and Regulatory Information for ammonia n-13

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Johns Hopkins Univ AMMONIA N 13 ammonia n-13 INJECTABLE;INTRAVENOUS 204514-001 Aug 19, 2014 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Wa Univ Sch Med AMMONIA N 13 ammonia n-13 INJECTABLE;INTRAVENOUS 204506-002 Feb 13, 2026 RX No Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Gen Hosp AMMONIA N 13 ammonia n-13 INJECTABLE;INTRAVENOUS 207025-001 Feb 3, 2016 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Petnet AMMONIA N 13 ammonia n-13 INJECTABLE;INTRAVENOUS 204510-001 Nov 2, 2015 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.